论文信息 - Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations - 字舞流文

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

M. Ladanyi | R. Somwar | E. de Stanchina | Y. Iwasawa | M. Davare | M. Mattar | S. Ohkubo | S. Kunte | K. Ishida | H. Fujita | K. Funabashi | M. Vojnic | I. Khodos | L. Delasos | I. Odintsov | Wakako Yano | A. Lui | E. Lovati | R. Kurth | Q. Chang | Y. Lu | Yukari Yamada | Isao Miyazaki | Masanori Kato | Tatsuya Suzuki | Tom Zhang | Kentaro Wakayama | Ryan Cheng | Kota Ishizawa | Ryuichiro Terada | Claudio Giuliano | Annalisa Bonifacio | Emily H. Cheng